Financial Security Advisor’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,584
Closed -$324K 122
2024
Q2
$324K Sell
11,584
-212
-2% -$5.84K 0.11% 75
2024
Q1
$327K Sell
11,796
-73
-0.6% -$2.03K 0.11% 76
2023
Q4
$342K Sell
11,869
-2,669
-18% -$80.7K 0.13% 74
2023
Q3
$482K Buy
+14,538
New +$514K 0.22% 54

Other funds holding PFE

Financial Security Advisor's PFE Position: Q3 2024 in Review

Financial Security Advisor sold out of Pfizer (PFE) in Q3 2024, closing a stake of 11,584 shares — an estimated $324K sold.

Financial Security Advisor first reported a position in PFE in Q3 2023 and held it in 4 quarters. The position peaked at $482K in Q3 2023. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Financial Security Advisor reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Financial Security Advisor sold 11,584 Pfizer shares in Q3 2024, an estimated $324K.
  • Financial Security Advisor first reported a position in Pfizer in Q3 2023 and held it in 4 quarters.
  • Financial Security Advisor's Pfizer position peaked at $482K in Q3 2023.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Financial Security Advisor's 13F filing for Q3 2024, filed 30 Oct 2024.